PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $24,000 | -71.8% | 9,898 | -73.4% | 0.02% | -67.1% |
| Q1 2017 | $85,000 | -69.0% | 37,230 | -71.2% | 0.07% | -38.1% |
| Q4 2016 | $274,000 | +15.6% | 129,480 | +83.3% | 0.11% | -28.5% |
| Q3 2016 | $237,000 | +15.6% | 70,622 | +8.1% | 0.16% | +3.9% |
| Q2 2016 | $205,000 | -32.3% | 65,341 | -28.3% | 0.15% | -27.6% |
| Q1 2016 | $303,000 | – | 91,141 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |